(Q41592367)

English

Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy

scientific article published on August 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 October 2017

1 reference

Europe PubMed Central

Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy (English)

1 reference

Europe PubMed Central

4 October 2017

5

object named as

T Unger

1 reference

Europe PubMed Central

4 October 2017

author name string

Y C Zhu

1

1 reference

Europe PubMed Central

4 October 2017

Y Z Zhu

2

1 reference

Europe PubMed Central

4 October 2017

P Gohlke

3

1 reference

Europe PubMed Central

4 October 2017

H M Stauss

4

1 reference

Europe PubMed Central

4 October 2017

language of work or name

0 references

publication date

1 August 1997

1 reference

Europe PubMed Central

4 October 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

4 October 2017

80

1 reference

Europe PubMed Central

4 October 2017

110A-117A

1 reference

Europe PubMed Central

4 October 2017

3A

1 reference

Europe PubMed Central

4 October 2017

Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

The effects of long-term pressure-overload and aging on the myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effect on the myocardial energy metabolism of angiotensin-converting enzyme inhibition in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Energetic changes of myocardium as an adaptation to chronic hemodynamic overload and thyroid gland activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Cellular distribution of angiotensin-converting enzyme after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Protein tyrosine phosphatase inhibition by angiotensin II in rat pheochromocytoma cells through type 2 receptor, AT2.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Inhibition of angiotensin converting enzyme: mechanism and substrate dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Distribution and metabolism of angiotensin I and II in the blood vessel wall

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Converting enzyme inhibitors in cardiovascular therapy: current status and future potential

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Angiotensin II receptor antagonists and the kidney.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Patterns of myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Remodeling of the rat right and left ventricles in experimental hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Angiotensin II and left ventricular growth in newborn pig heart

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Long-term angiotensin II antagonism in spontaneously hypertensive rats: effects on blood pressure and cardiovascular amplifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Exercise-induced myocardial capillary growth in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Capillary neoformation in the rat heart--stereological studies on papillary muscles in hypertrophy and physiologic growth

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

The angiotensin AT2 receptor: searching for signal-transduction pathways and physiological function.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Signals for the remodeling of the cardiac interstitium in systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9149(97)00465-7

1 reference

Europe PubMed Central

4 October 2017

1 reference

Europe PubMed Central

4 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41592367&oldid=1924808406"